DEVELOPMENT OF GD2 TARGETING THERANOSTICS FOR NEUROBLASTOMA
dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Poot, A.J. | |
dc.contributor.author | Sünnen, Emma | |
dc.date.accessioned | 2023-12-09T00:01:04Z | |
dc.date.available | 2023-12-09T00:01:04Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/45627 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | Using the concept of theranosics to modify the antibody Dinutuximab, an approved medicine for treatment of neuroblastoma, with as goal to have a better understanding of the antibody. | |
dc.title | DEVELOPMENT OF GD2 TARGETING THERANOSTICS FOR NEUROBLASTOMA | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.courseuu | Drug Innovation | |
dc.thesis.id | 26455 |